NUS scientists develop new technology to customize optimal drug 'cocktail' for myeloma patients

NUS scientists develop new technology to customize optimal drug 'cocktail' for myeloma patients

August 13, 2018 A multidisciplinary team of researchers from the National University of Singapore (NUS) has developed an artificial intelligence (AI) technology platform that could potentially change the way drug combinations are being designed, hence enabling doctors to determine the most effective drug combination for a patient quickly. Applying the platform towards drug resistant multiple […]

NUS researchers develop AI platform to rapidly identify optimal personalised drug combinations for myeloma patients

NUS researchers develop AI platform to rapidly identify optimal personalised drug combinations for myeloma patients

Newswise — A multidisciplinary team of researchers from the National University of Singapore (NUS) has developed an artificial intelligence (AI) technology platform that could potentially change the way drug combinations are being designed, hence enabling doctors to determine the most effective drug combination for a patient quickly. Applying the platform towards drug resistant multiple myeloma, […]

Most midcaps looking attractive; these 2 stocks could offer double-digit return in FY19

Most midcaps looking attractive; these 2 stocks could offer double-digit return in FY19

Akash Jain Ajcon Global The Q1 FY19 earnings season has been above our expectations. Going forward, street participants would have an eye on global developments, especially the US-China trade war, progress of the monsoon, macroeconomic data, investment by foreign portfolio investors (FPIs) and domestic institutional investors (DIIs), movement of the rupee against the dollar and […]

Chengwei Capital-backed Tot Biopharm secures $102m Series B funding

Chengwei Capital-backed Tot Biopharm secures $102m Series B funding

Suzhou-headquartered biotechnology firm Tot Biopharm, which focuses on high-end anti-tumour drugs, has raised $102 million in a Series B funding round co-led by existing investor Chengwei Capital, asset manager 99Fund, and China Universal (Cayman) GP Ltd. The latest funding round was also joined by investors that joined in earlier rounds, including Center Laboratories Group, Vivo […]

On-time approval, on to market for Onpattro as first RNAi therapy

By Marie PowersNews Editor FDA approval of patisiran, branded Onpattro, to treat hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) represents several firsts for Alnylam Pharmaceuticals Inc., not least of which is the distinction of bringing the initial RNAI interference (RNAi) drug to market. Although the Cambridge, Mass.-based company also beat competitor Akcea Therapeutics Inc., which is developing […]

Shuttered Elko brothel may get new owner

Shuttered Elko brothel may get new owner

ELKO – Mona’s Ranch could soon have its suspended brothel license restored and a new owner. Elko City Council will be asked at its Aug. 14 meeting to consider approving applications for a house of prostitution license and retail liquor license from Louis Goldberg, who was general manager of Mona’s Ranch and hopes to buy […]

Tennessee executes killer with controversial drugs that Justice Sotomayor said could inflict 'torturous pain'

Tennessee executes killer with controversial drugs that Justice Sotomayor said could inflict 'torturous pain'

by Deanna Paul August 9 at 8:55 PM Email the author BREAKING: Tennessee executes killer with controversial drugs that Supreme Court Justice Sotomayor said would likely inflict ‘torturous pain’ Billy Ray Irick, who was convicted of the 1985 rape and murder of a 7-year-old girl, became the first inmate put to death in the state […]

New generic methadone hydrochloride drug gets FDA nod

New generic methadone hydrochloride drug gets FDA nod

An abuse-deterrent opioid drug recently got the approval of the U.S. Food and Drug Administration (FDA) in what’s considered to be a landmark move against drug addiction in the country. Elite Pharmaceuticals’ abbreviated new drug application (ANDA) for generic methadone hydrochloride, consisting of 5 and 10 mg tablets, received FDA approval amid growing concerns of […]

Omeros Corporation Reports Second Quarter 2018 Financial Results

Omeros Corporation Reports Second Quarter 2018 Financial Results

SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER) today announced recent highlights and developments as well as financial results for the second quarter ended June 30, 2018, which include: 2Q 2018 total and OMIDRIA® revenues were $1.7 million, compared to $17.2 million in 2Q 2017; the decrease was due to the significantly reduced usage of OMIDRIA by ambulatory […]